Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2026-03-01 @ 9:33 AM
Study NCT ID:
NCT00622700
Status:
COMPLETED
Last Update Posted:
2017-03-13
First Post:
2008-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-14
First Submit QC Date:
None
Study First Post Date:
2008-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-07
Results First Submit QC Date:
None
Results First Post Date:
2014-12-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-01-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-01-20
Last Update Post Date:
2017-03-13
Last Update Post Date Type:
ACTUAL